Arnold Trzeciak
15Patents
9h-index
18Co-inventors
69Inventor score
Filing activity: Sep 20, 1976 → Jan 14, 1997
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5039805A | Novel benzoic and phenylacetic acid derivatives | Chemistry; Metallurgy | 61 | Expired |
| US5084466A | Novel carboxamide pyridine compounds which have useful pharmaceutical utility | Emerging Cross-Sectional Technologies | 51 | Expired |
| US5273982A | Acetic acid derivatives | Human Necessities | 38 | Expired |
| US5399585A | Carboxamides and sulfonamides compounds which have useful pharmaceutical utility | Emerging Cross-Sectional Technologies | 26 | Expired |
| US4504415A | Synthesis of thymosin .alpha..sub.1 and desacetyl thymosin .alpha..sub.1 | Emerging Cross-Sectional Technologies | 21 | Expired |
| US5256812A | Carboxamides and sulfonamides | Emerging Cross-Sectional Technologies | 21 | Expired |
| US5644024A | Tetrahydronaphthalene derivatives | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5430024A | Peptides bearing N-terminal amidino moieties and their use as inhibitors of platelet aggregation | Human Necessities | 10 | Expired |
| US4517119A | Synthesis of thymosin .alpha..sub.1 | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5663297A | Antithrombic peptides | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5811548A | Tri-and tetracyclic compounds | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5759827A | Acylated oligopeptides for transfecting cells | Chemistry; Metallurgy | 3 | Expired |
| US5811389A | Tri- and tetracyclic compounds | Emerging Cross-Sectional Technologies | 2 | Expired |
| US4066635A | L-Pyroglutamyl-L-histidyl-L-prolyl-beta-alaninamide and salts | Chemistry; Metallurgy | 1 | Expired |
| US6030602A | Peptide conjugates for transfecting cells | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.